ADAMTS2 and Autoimmunity: PNPi treatment also increased serum cytokine levels and accelerated the onset of other manifestations of autoimmunity in the MRL-LPR model, including lymphadenopathy, proteinuria, and glomerulonephritis (Figure 8, E–H, and Supplemental Figure 6, F and G).